Jogo Health, a NYC-based medtech company treating chronic pain and neuromuscular disorders, raised $5.5M in funding.
The round was led by Hourglass Ventures. Due to high demand, the company is opening the round to public retail investors via a Regulation CF community investment round on Wefunder, inviting retail investors to join alongside firms like Mayo Clinic Ventures.
The company intends to use the funds to expand operations and development efforts.
Led by CEO Sanjai Murali, Jogo Health is a medtech company treating chronic pain and neuromuscular disorders, including stroke, migraines, and incontinence. Cleared by the FDA and reimbursed by Medicare and commercial insurance, its wearable technology and app leverage the brain’s natural neuroplasticity to offer relief from pain and aid recovery from neuromuscular conditions, expanding a $380B market without drugs or surgery. Jogo has already treated 25,000+ patients and completed 100,000+ sessions across 50+ hospital partners, including Mayo Clinic and Mount Sinai.
FinSMEs
19/06/2024